Yoshinoya Strengthens Rare Disease Pipeline with IntraBio Acquisition

· gurufocus.com

Japanese pharmaceutical company Yoshinoya has announced the acquisition of IntraBio, aiming to enhance its capabilities in rare disease research and development

Japanese pharmaceutical company Yoshinoya has announced the acquisition of IntraBio, aiming to enhance its capabilities in rare disease research and development...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI